• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » ICH’s E8 Revisions Now Ready for Regulatory Approval

ICH’s E8 Revisions Now Ready for Regulatory Approval

October 11, 2021

ICH’s long-awaited E8(R1) guidelines have been finalized, and the guidelines are now awaiting implementation by the FDA and other regulatory agencies.

Together with E6(R3), which is considerably further behind and is expected to come out in draft form in early 2022, the guidelines seek to make quality a central component and concern in clinical trials. ICH E6 — Good Clinical Practice focuses on the responsibilities of sponsors, investigators and other clinical trial stakeholders, while ICH E8 — General Considerations for Clinical Trials addresses broader principles of quality in clinical trials (CenterWatch Weekly, Sept. 6).

E8(R1) is a revision that modernizes the original E8 guidelines adopted by the FDA way back in 1997. The modernized version lays out the concept of risk-based quality management (RBQM).

Importantly, it delves into quality by design, which entails focusing on “critical-to-quality factors” to ensure data generated are reliable, study participants are protected and risks are managed based on their importance. In identifying a basic set of factors that are paramount to ensuring the quality of the study, sponsors should use an approach that establishes a culture of open dialogue, focuses on essential study activities and engages stakeholders in the design of the study. A feasibility assessment and periodic reviews of critical-to-quality factors should also be conducted.

There is also a section that discusses key components of trial designs: patient population; treatment; the control group and response variable; methods to reduce bias; statistical analysis; and data sources. This section, the guidelines say, is meant to help identify critical-to-quality factors that are needed to meet the trial’s objectives while also allowing for a flexible design and efficiency in running the trial. While its focus is on interventional studies, it’s also relevant to observational studies and is expected to apply to new data sources and trial types developed in the future.

The E8(R1) guidelines also offer quality principles and approaches for study conduct, safety monitoring and study reporting.

Read the full final guidelines here: https://bit.ly/2Yr5hsj.

To view more CenterWatch Weekly stories, click here.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing